Travere Therapeutics Email Format
Biotechnology ResearchCalifornia, United States501-1000 Employees
Travere Therapeutics is a biotechnology research company based in San Diego that focuses on identifying, developing and delivering therapies for people with rare diseases. It operates in the biotechnology industry, has 501 to 1000 employees, and is headquartered at 3611 Valley Centre Drive Suite 300, San Diego, CA 92130, United States; more information is available on its website travere.com. In 2026, Travere executed a strategic asset acquisition from Everest Medicines, adding the civorebrutinib BTKi asset to its portfolio. The company announced leadership changes in 2026, appointing Inrig as executive vice president, head of research and development and chief medical officer, and stating that chief research officer William Rote plans to retire in 2027. Travere has a history of collaboration, notably a long-standing partnership with the Warren Center for Neuroscience Drug Discovery since 2015 to pursue treatments for NGLY1 deficiency.
1-888-653-2347 
support@leadiq.com 
